Polynovo (ASX:PNV)
ASX announcement history & article coverage
Transparent by design.
Announcments by Polynovo (ASX:PNV) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Change in substantial holding
Becoming a substantial holder
Ceasing to be a substantial holder
Change in substantial holding
Ceasing to be a substantial holder
Change in substantial holding
U.S. Pivotal Trial CSR Finalised and PMA Submission Update
PolyNovo finalizes clinical report and revises US PMA submission to late 2026 following FDA guidance update
Change in substantial holding
Ceasing to be a substantial holder
Becoming a substantial holder
Response to ASX Price Query
PolyNovo denies undisclosed info amid unusual trading, confirms ASX compliance
Change in substantial holding
Updated Share Trading Policy
Appointment of Dr Marthe DOmbrain as Chief Scientific Offic